Шляхи оптимізації лікування хворих із незадовільним прогнозом кінцевого зросту

О. В. Большова, О. Я. Самсон, Н. А. Спринчук

Повний текст:

PDF

Посилання


Oostdijk W., Drop S.J.S., Odink R.J.H. et al. Long-term results with a slow-release gonadotrophin-release hormone agonist in central precocious puberty // Acta Paediatr. [Suppl] – 2001. – Vol. 372. – P. 39-45. https://doi.org/10.1111/j.1651-2227.1991.tb17967.x

J. Yanovski, S.R. Rose, G. Municchi [et al.] Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature // NEJM. – 2002. – Vol. 348. – P. 908-917. https://doi.org/10.1056/nejmoa013555

J.G. Buchlis, L. Irizarry, B.C. Crotzer [et al.] Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure // J. Clin. Endocrinol. Metabol. – 1998. – Vol. 83. – P. 1075-1079. https://doi.org/10.1210/jc.83.4.1075

M. Toumba, I. Bacopoulou, S.C. Savva, N. Skordis. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height // Indian Pediatr. – 2007. – Vol. 44, №7. – P. 497-502.

Muthusamy K., Elamin M.B., Smushkin G. Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis // The Journal of Clinical Endocrinology & Metabolism. – 2010. – Vol. 95. – №9. – P. 4161-4172. https://doi.org/10.1210/jc.2009-2616

Большова О. В., Самсон О. Я., Музь В. А. Особливості перебігу пубертатного періоду у хворих з соматотропною недостатністю. Методи медикаментозної корекції статевого дозрівання // Педіатрія, акушерство і гінекологія. – 2005. – №2.- С. 41-43.

M. Tauber, B. Berro, V. Delagnes [et al.] Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study // J. Clin. Endocrinol. Metab. – Vol. 88, 13. – P. 1179-1183. https://doi.org/10.1210/jc.2002-020974

G. Saggese, G. Cesaretti, S. Barsanti, A. Rossi. Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls // J. Pediatr. – 1995. – Vol. 126. – P. 468-473. https://doi.org/10.1016/s0022-3476(95)70473-6

J.C. Carel, M. Roger, S. Ispas [et al.] Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment / / J. Clin. Endocrinol. Metabol. – 2005. – Vol. 84, №6. – P. 1973-1978. https://doi.org/10.1210/jcem.84.6.5647

E.C. Walvoord, O.H. Pescovitz. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations // Pediatrics. – 1999. – Vol. 104. – P. 1010-1014.

A. Morishima, M.M. Grumbach, E.R. Simpson [et al.] Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens // J. Clin. Endocrinol. Metabolism. - 1995. – Vol. 80. – P. 3689-3698. https://doi.org/10.1210/jcem.80.12.8530621

Horton W.A., Hecht J.T. Growth hormone therapy in achondroplasia // Am. J. Med. Genet. – 1992. – Vol. 42. – P. 667-670. https://doi.org/10.1002/ajmg.1320420508

Nguyen A.T., Brown J.J., Warne G.L. Growth in congenital adrenal hyperplasia // Indian J. Pediatr. – 2006. – Vol. 73, №1. – P. 89-93. https://doi.org/10.1007/bf02758268

K. Lin-Su, M.G. Vogiatzi, I. Marshall [et al.] Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia // J. Clin. Endocrinol. Metabolism. – 2005. – Vol. 90, №6. – P. 3318-3325. https://doi.org/10.1210/jc.2004-2128

Allen D.B., Julius J.R., Breen T.J., Attie K.M., Allen D.B. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study // J. Clin. Endocrinol. Metab. – 1998. – Vol. 83. – P. 2824-2829. https://doi.org/10.1210/jcem.83.8.5036

New M. Factors determining final height in congenital adrenal hyperplasia // J. Pediatr. Endocrinol. Metab. – 2001. – Vol. 14, Suppl. 2 – P. 933-937. https://doi.org/10.1515/jpem-2001-s204

Aycan Z., Ocal G., Berberoglu M., Cetinkaya E. [et al.] Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential // J. Pediatr. Endocrinol. Metab. – 2006. – Vol. 19(3). – P. 245-251. https://doi.org/10.1515/jpem.2006.19.3.245

Khadilkar V.V., Khadilkar A.V., Maskati G.B. Impact of availability of oral hydrocortisone on growth of children with CAH // Indian J. Pediatr. – 2005. – Vol. 72(4). – P. 301-303. https://doi.org/10.1007/bf02724009

J.-C. Carel, E.A. Eugster, A. Rogol [et al.] Consensus statement on the use of gonadotropine-releasing hormone analogs in children // Pediatrics. – 2009. – Vol. 123. – P. 752-762. https://doi.org/10.1542/peds.2008-1783

Dacou-Voutetakis C., Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue // Ann. NY Acad. Sci . – 1993. – Vol. 687. – P. 250-254. https://doi.org/10.1111/j.1749-6632.1993.tb43873.x


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.2(39).2012.82479



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter